Clinical decision support
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
The organizations will codevelop an atrial fibrillation program that provides clinical decision support tools and patient coaching between clinical visits.
Sonio will remain an independent company following the acquisition.
The company's stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.
Med-Gemini-3D can read 3D scans, generate radiology reports and answer questions, while Med-Gemini-Polygenic can predict health outcomes based on genomic data.
Payments and revenue cycle-management company Sift Healthcare, nursing-scheduling and management platform In-House Health, and analytics and risk-stratification company OptMyCare also secured funding.
It will validate BrainEye's 60-second eye movement test to about 500 participants.
Also, Clanwilliam has formally established its ANZ division.